Citadel Advisors
RXST icon

Citadel Advisors’s RxSight RXST Stock Holding History

Citadel Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Sell
700,736
-417,983
-37% -$2.52M ﹤0.01% 5457
2026
Q1 		$6.89M Buy
1,118,719
+72,897
+7% +$605K ﹤0.01% 3834
2025
Q4 		$10.9M Sell
1,045,822
-244,322
-19% -$2.45M ﹤0.01% 3147
2025
Q3 		$11.6M Buy
1,290,144
+262,281
+26% +$2.3M ﹤0.01% 3053
2025
Q2 		$13.4M Buy
1,027,863
+797,642
+346% +$12M ﹤0.01% 2653
2025
Q1 		$5.81M Sell
230,221
-763,946
-77% -$22.7M ﹤0.01% 3642
2024
Q4 		$34.2M Buy
994,167
+782,424
+370% +$35.3M 0.01% 1622
2024
Q3 		$10.5M Buy
211,743
+84,253
+66% +$4.32M ﹤0.01% 2830
2024
Q2 		$7.67M Sell
127,490
-3,789
-3% -$217K ﹤0.01% 3146
2024
Q1 		$6.77M Buy
131,279
+22,952
+21% +$1.13M ﹤0.01% 3499
2023
Q4 		$4.37M Buy
108,327
+105,526
+3,767% +$3.1M ﹤0.01% 3998
2023
Q3 		$78.1K Sell
2,801
-255,473
-99% -$7.62M ﹤0.01% 11204
2023
Q2 		$7.44M Buy
258,274
+211,154
+448% +$4.7M ﹤0.01% 3072
2023
Q1 		$786K Buy
47,120
+38,683
+458% +$546K ﹤0.01% 7320
2022
Q4 		$107K Sell
8,437
-15,459
-65% -$188K ﹤0.01% 11122
2022
Q3 		$287K Sell
23,896
-6,092
-20% -$83.7K ﹤0.01% 9679
2022
Q2 		$422K Buy
+29,988
New +$396K ﹤0.01% 9044

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors's RXST Position: Q2 2026 in Review

Citadel Advisors reduced its RxSight (RXST) stake by 37% in Q2 2026, selling an estimated $2.52M and leaving 700,736 shares worth $3.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5457.

Citadel Advisors first reported a position in RXST in Q2 2022 and has held it in 17 quarters since. The position peaked at $34.2M in Q4 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Citadel Advisors held 700,736 shares of RxSight worth $3.38M as of Q2 2026.
  • Citadel Advisors sold 417,983 RxSight shares in Q2 2026, an estimated $2.52M.
  • RxSight made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5457 holding.
  • Citadel Advisors first reported a position in RxSight in Q2 2022 and has held it in 17 quarters since.
  • Citadel Advisors's RxSight position peaked at $34.2M in Q4 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.